The clinical application of enzyme estimations in the cerebrospinal fluid (CSF) is reviewed. Relevant features of the physiology of the CSF in man, the precautions needed to obtain representative samples and valid controls, and the sources of enzyme in CSF are considered. Brief reference is made to the application of CSF enzyme assays in cerebrovascular disease and tumour diagnosis and in other neurological conditions including head injury and cerebral anoxia.
Although at least 30 enzymes have been demonstrated in the CSF of man only glutamic-oxaloacetic transaminase (GOn and lactate dehydrogenase (LDH) have received much clinical attention. Lesser studies have been made on phosphohexose isomerase, isocitric dehydrogenase, phosphatases, ,B-glucuronidase, aldolase and creatine kinase. No comprehensive review has appeared in recent years. Green (1958) gives a fairly full account of papers up to that date and a few more recent works are quoted by Plum (1964) . A review is in preparation for publication from this department.
Attempts have been made to apply CSF enzyme estimations: (1) in cerebrovascular disease, to assess the presence, extent and progression of infarction and in efforts to distinguish thrombosis from haemorrhage, (2) to cerebral tumour suspects, as an aid to diagnosis and to differentiation of benign from malignant growths and tumours from infarcts, and to detect recurrence, (3) in cases of head injury, to assess severity and guide prognosis, and (4) in the assessment of perinatal hypoxia. In meningitis there is increased activity of several enzymes in CSF: correlation with the different types of meningitis has not been fully investigated. Enzyme changes have been reported in the CSF from cases of demyelinating diseases but no recent studies seem to have been made here.
Sources of enzymes in the CSF are: (1) from the blood plasma via the choroid plexus, (2) from addition of whole blood in trauma and strokes and, more rarely, by haemorrhage into tumours and from bleeding secondary to coagulation defects, (3) from excess of white blood cells in meningitis and leucaemia, (4) from normal brain damaged by infarction, external trauma and internal compression, or rendered transiently more permeable by hypoxia Paper read at the Southern Eniliand and South Wales Rellional meeting, London, November, 1967. or by air in the theca, (5) from tumours, though the actual origin of the enzyme increases seen here remains in doubt, and, (6) from proliferating brain tissue around tumours.
To obtain valid results a number of considerations must be kept in mind: there is a chemical gradient down the cerebrospinal axis so that the volume of fluid that can be withdrawn by lumbar puncture and still be truly "lumbar" is limited. Of the total normal adult CSF volume of 140 ml., about 20 mI. lies in the ventricles, 30 ml. in the lumbar subarachnoid space and the rest in the cranial subarachnoid space. Blood-stained fluid, from a traumatic tap, is best avoided; if it must be used, the cells should be separated immediately as they constitute the main source of contaminating enzyme. Only minimal centrifugal force should be used. Enzymes in CSF are less stable than in plasma and the normal levels are lower. A significant loss occurs on standing for 5 hours at room temperature. Samples withdrawn after the injection of air for an encephalogram must not be used, as falsely high enzyme activities are found. Following the irritant action of the air, the additional enzyme was shown to come from the CNS and not the plasma.
The application of CSF enzyme analysis to the investigation of cerebrovascular disorders has, on the whole, been disappointing. Both GOT and LDR are found to rise after cerebral infarction, the extent has varied in different studies. CSF changes are probably more frequent than increases of plasma enzyme. Maximum values occur at between 3 and 5 days after the onset and increased activity may last for from a few days to many months. In rapidly fatal cases with massive infarction, the finding of a CSF GOT above the plasma level is more significant than the actual height of the rise, which may never have time to develop. With survival, the extent of the rise correlates fairly well with the size of the infarct.
Cerebral tumours are sometimes associated with increased LDH activity in the CSF. Though some investigators have failed to find any change, most authors find a rise in about two-thirds of the cases. The high LDR activity in the fluid of cystic cerebral tumours was not reflected in the ventricular CSF, where raised values seemed to depend more on the nearness of the lesion to the ventricular wall. Both the total LDR and the increased proportion of LDH p in a cyst fluid correlated with the degree of 33 malignancy of the parent tumour. The LDH agar gel electropherograms of cyst fluids and their parent tumours were sufficiently alike to allow prediction of the degree of malignancy of the tumour from the cyst fluid, a useful application of enzyme analysis when no biopsy was available.
GOT, phosphatases, leucine aminopeptidase, glucose phosphate isomerase, ,a-glucuronidase and isocitric dehydrogenase have been investigated to a lesser extent in the CSF of patients with cerebral tumours; isocitric dehydrogenase appears to have some advantages.
